Logo image of NU

NU HOLDINGS LTD/CAYMAN ISL-A (NU) Stock Fundamental Analysis

NYSE:NU - New York Stock Exchange, Inc. - KYG6683N1034 - Common Stock - Currency: USD

12.3  -0.11 (-0.89%)

After market: 12.35 +0.05 (+0.41%)

Fundamental Rating

5

NU gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 392 industry peers in the Banks industry. While NU is still in line with the averages on profitability rating, there are concerns on its financial health. NU is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

NU had positive earnings in the past year.
In the past year NU had a positive cash flow from operations.
In multiple years NU reported negative net income over the last 5 years.
NU had a positive operating cash flow in 4 of the past 5 years.
NU Yearly Net Income VS EBIT VS OCF VS FCFNU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

NU has a Return On Assets of 3.97%. This is amongst the best in the industry. NU outperforms 99.49% of its industry peers.
With an excellent Return On Equity value of 24.98%, NU belongs to the best of the industry, outperforming 99.49% of the companies in the same industry.
NU has a Return On Invested Capital of 4.86%. This is amongst the best in the industry. NU outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 3.97%
ROE 24.98%
ROIC 4.86%
ROA(3y)1.7%
ROA(5y)0.52%
ROE(3y)11.47%
ROE(5y)-1.69%
ROIC(3y)N/A
ROIC(5y)N/A
NU Yearly ROA, ROE, ROICNU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

NU has a Profit Margin of 17.88%. This is in the lower half of the industry: NU underperforms 68.11% of its industry peers.
NU's Operating Margin of 25.05% is amongst the best of the industry. NU outperforms 98.98% of its industry peers.
NU's Gross Margin of 44.82% is amongst the best of the industry. NU outperforms 100.00% of its industry peers.
NU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.05%
PM (TTM) 17.88%
GM 44.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y2.4%
NU Yearly Profit, Operating, Gross MarginsNU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

NU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NU has more shares outstanding
Compared to 5 years ago, NU has more shares outstanding
NU has a worse debt/assets ratio than last year.
NU Yearly Shares OutstandingNU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
NU Yearly Total Debt VS Total AssetsNU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

NU has an Altman-Z score of 0.47. This is a bad value and indicates that NU is not financially healthy and even has some risk of bankruptcy.
NU has a better Altman-Z score (0.47) than 100.00% of its industry peers.
NU has a debt to FCF ratio of 8.83. This is a slightly negative value and a sign of low solvency as NU would need 8.83 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.83, NU is not doing good in the industry: 77.55% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.83 is on the high side and indicates that NU has dependencies on debt financing.
NU has a worse Debt to Equity ratio (3.83) than 95.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.83
Debt/FCF 8.83
Altman-Z 0.47
ROIC/WACC0.37
WACC13.26%
NU Yearly LT Debt VS Equity VS FCFNU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

NU has a Current Ratio of 0.14. This is a bad value and indicates that NU is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Current ratio value of 0.14, NU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 0.14 indicates that NU may have some problems paying its short term obligations.
NU has a better Quick ratio (0.14) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
NU Yearly Current Assets VS Current LiabilitesNU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.27% over the past year.
Looking at the last year, NU shows a very strong growth in Revenue. The Revenue has grown by 31.52%.
NU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.85% yearly.
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)31.52%
Revenue growth 3Y89.29%
Revenue growth 5Y79.85%
Sales Q2Q%18.71%

3.2 Future

NU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.83% yearly.
Based on estimates for the next years, NU will show a very strong growth in Revenue. The Revenue will grow by 26.65% on average per year.
EPS Next Y31.35%
EPS Next 2Y36.31%
EPS Next 3Y39.83%
EPS Next 5YN/A
Revenue Next Year21.61%
Revenue Next 2Y23.9%
Revenue Next 3Y26.65%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NU Yearly Revenue VS EstimatesNU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
NU Yearly EPS VS EstimatesNU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.63, which means the current valuation is very expensive for NU.
84.44% of the companies in the same industry are cheaper than NU, based on the Price/Earnings ratio.
NU is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.71, NU is valued correctly.
75.00% of the companies in the same industry are cheaper than NU, based on the Price/Forward Earnings ratio.
NU's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE 25.63
Fwd PE 14.71
NU Price Earnings VS Forward Price EarningsNU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NU is valued cheaper than 98.98% of the companies in the same industry.
63.01% of the companies in the same industry are cheaper than NU, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.5
EV/EBITDA 18.22
NU Per share dataNU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of NU may justify a higher PE ratio.
A more expensive valuation may be justified as NU's earnings are expected to grow with 39.83% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y36.31%
EPS Next 3Y39.83%

0

5. Dividend

5.1 Amount

No dividends for NU!.
Industry RankSector Rank
Dividend Yield N/A

NU HOLDINGS LTD/CAYMAN ISL-A

NYSE:NU (8/8/2025, 8:04:01 PM)

After market: 12.35 +0.05 (+0.41%)

12.3

-0.11 (-0.89%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-14 2025-08-14/amc
Inst Owners79.05%
Inst Owner Change0.26%
Ins Owners0.29%
Ins Owner Change0%
Market Cap59.27B
Analysts75.2
Price Target14.34 (16.59%)
Short Float %2.9%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.54%
Min EPS beat(2)-6.52%
Max EPS beat(2)-2.56%
EPS beat(4)2
Avg EPS beat(4)4.79%
Min EPS beat(4)-6.52%
Max EPS beat(4)22.21%
EPS beat(8)5
Avg EPS beat(8)4.56%
EPS beat(12)9
Avg EPS beat(12)32.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.7%
Min Revenue beat(2)-11.83%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)-4.12%
Min Revenue beat(4)-11.83%
Max Revenue beat(4)0.42%
Revenue beat(8)6
Avg Revenue beat(8)0.04%
Revenue beat(12)9
Avg Revenue beat(12)2.07%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.4%
PT rev (3m)1.67%
EPS NQ rev (1m)1.3%
EPS NQ rev (3m)-0.05%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)2.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.09%
Valuation
Industry RankSector Rank
PE 25.63
Fwd PE 14.71
P/S 4.93
P/FCF 15.5
P/OCF 14.62
P/B 6.89
P/tB 7.64
EV/EBITDA 18.22
EPS(TTM)0.48
EY3.9%
EPS(NY)0.84
Fwd EY6.8%
FCF(TTM)0.79
FCFY6.45%
OCF(TTM)0.84
OCFY6.84%
SpS2.5
BVpS1.79
TBVpS1.61
PEG (NY)0.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.97%
ROE 24.98%
ROCE 28.38%
ROIC 4.86%
ROICexc 5.53%
ROICexgc 5.68%
OM 25.05%
PM (TTM) 17.88%
GM 44.82%
FCFM 31.79%
ROA(3y)1.7%
ROA(5y)0.52%
ROE(3y)11.47%
ROE(5y)-1.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y2.4%
F-Score7
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 3.83
Debt/FCF 8.83
Debt/EBITDA 10.67
Cap/Depr 288.46%
Cap/Sales 1.92%
Interest Coverage 41.74
Cash Conversion 131.11%
Profit Quality 177.83%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.47
F-Score7
WACC13.26%
ROIC/WACC0.37
Cap/Depr(3y)276.52%
Cap/Depr(5y)220.29%
Cap/Sales(3y)2.04%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y31.35%
EPS Next 2Y36.31%
EPS Next 3Y39.83%
EPS Next 5YN/A
Revenue 1Y (TTM)31.52%
Revenue growth 3Y89.29%
Revenue growth 5Y79.85%
Sales Q2Q%18.71%
Revenue Next Year21.61%
Revenue Next 2Y23.9%
Revenue Next 3Y26.65%
Revenue Next 5YN/A
EBIT growth 1Y60.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y511.41%
FCF growth 3YN/A
FCF growth 5Y52.3%
OCF growth 1Y425.56%
OCF growth 3YN/A
OCF growth 5Y54.09%